Sapient Capital LLC Buys Shares of 4,974 The Allstate Co. (NYSE:ALL)

Sapient Capital LLC bought a new stake in shares of The Allstate Co. (NYSE:ALL) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund bought 4,974 shares of the insurance provider’s stock, valued at approximately $701,000.

Several other institutional investors and hedge funds also recently made changes to their positions in ALL. Cambridge Investment Research Advisors Inc. raised its position in shares of Allstate by 1.0% during the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 47,248 shares of the insurance provider’s stock valued at $5,264,000 after acquiring an additional 466 shares during the last quarter. Pinnacle Associates Ltd. bought a new stake in shares of Allstate in the 3rd quarter valued at $209,000. Stratos Wealth Partners LTD. increased its position in shares of Allstate by 21.6% in the 3rd quarter. Stratos Wealth Partners LTD. now owns 9,032 shares of the insurance provider’s stock valued at $1,006,000 after buying an additional 1,607 shares in the last quarter. Mn Services Vermogensbeheer B.V. increased its position in shares of Allstate by 2.8% in the 3rd quarter. Mn Services Vermogensbeheer B.V. now owns 128,873 shares of the insurance provider’s stock valued at $14,358,000 after buying an additional 3,500 shares in the last quarter. Finally, Brown Advisory Inc. increased its position in shares of Allstate by 6.5% in the 3rd quarter. Brown Advisory Inc. now owns 29,311 shares of the insurance provider’s stock valued at $3,266,000 after buying an additional 1,800 shares in the last quarter. Institutional investors own 76.47% of the company’s stock.

Allstate Stock Performance

NYSE:ALL traded down $1.00 during mid-day trading on Friday, hitting $168.18. The stock had a trading volume of 1,668,295 shares, compared to its average volume of 1,508,644. The Allstate Co. has a twelve month low of $100.57 and a twelve month high of $177.37. The stock has a market cap of $44.39 billion, a price-to-earnings ratio of 37.13, a PEG ratio of 0.39 and a beta of 0.51. The company’s 50 day simple moving average is $166.06 and its 200 day simple moving average is $150.95. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.37 and a current ratio of 0.36.

Allstate (NYSE:ALL) last issued its earnings results on Thursday, May 2nd. The insurance provider reported $5.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.11 by $1.02. Allstate had a net margin of 2.31% and a return on equity of 14.44%. The business had revenue of $15.26 billion during the quarter, compared to the consensus estimate of $12.76 billion. During the same period last year, the business posted ($1.30) EPS. Allstate’s revenue was up 10.7% on a year-over-year basis. On average, equities research analysts forecast that The Allstate Co. will post 14.57 earnings per share for the current year.

Allstate Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, April 1st. Shareholders of record on Monday, March 4th were issued a $0.92 dividend. This is a boost from Allstate’s previous quarterly dividend of $0.89. This represents a $3.68 annualized dividend and a yield of 2.19%. The ex-dividend date of this dividend was Friday, March 1st. Allstate’s dividend payout ratio is currently 81.24%.

Insider Buying and Selling at Allstate

In other Allstate news, insider John E. Dugenske sold 31,000 shares of the stock in a transaction dated Tuesday, March 26th. The shares were sold at an average price of $170.20, for a total value of $5,276,200.00. Following the transaction, the insider now directly owns 63,731 shares of the company’s stock, valued at approximately $10,847,016.20. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, insider John E. Dugenske sold 31,000 shares of the firm’s stock in a transaction that occurred on Tuesday, March 26th. The shares were sold at an average price of $170.20, for a total transaction of $5,276,200.00. Following the transaction, the insider now directly owns 63,731 shares of the company’s stock, valued at $10,847,016.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO John C. Pintozzi sold 4,000 shares of Allstate stock in a transaction on Tuesday, February 27th. The shares were sold at an average price of $159.47, for a total value of $637,880.00. Following the completion of the transaction, the chief accounting officer now directly owns 10,736 shares of the company’s stock, valued at $1,712,069.92. The disclosure for this sale can be found here. Insiders own 1.80% of the company’s stock.

Wall Street Analyst Weigh In

ALL has been the subject of a number of recent analyst reports. The Goldman Sachs Group upped their price objective on shares of Allstate from $164.00 to $195.00 and gave the company a “buy” rating in a research report on Monday, March 25th. Jefferies Financial Group raised shares of Allstate from a “hold” rating to a “buy” rating and upped their target price for the stock from $130.00 to $180.00 in a research note on Tuesday, January 9th. Piper Sandler upped their target price on shares of Allstate from $172.00 to $188.00 and gave the stock an “overweight” rating in a research note on Monday, April 1st. TheStreet raised shares of Allstate from a “c+” rating to a “b” rating in a research note on Wednesday, February 7th. Finally, Roth Mkm upped their target price on shares of Allstate from $175.00 to $200.00 and gave the stock a “buy” rating in a research note on Monday, April 8th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $174.18.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.